The Place of Estriol Add-Back Therapy in Women Treated with GnRH Agonist, with Reference to Bone Protection
Author:
Publisher
Springer Berlin Heidelberg
Link
http://link.springer.com/content/pdf/10.1007/978-3-662-04021-8_8
Reference38 articles.
1. Adamson GD (1992) Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists. Am J Obstet Gynecol 166: 746–751
2. Adashi EY (1994) Long-term gonadotropin-releasing hormone agonist therapy: the evolving issue of steroidal “add-back” paradigms. Human Reprod Update 9: 1380–1397
3. Arts J, Kuiper GGJM, Janssen JMMF, Gustafsson JA, Löwik CWGM, Pols HAP, Van Leeuwen JPTM (1997) Differential expression of estrogen receptors a and 13 mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology 138: 5067–5070
4. Black LJ, Sato M, Rowley ER, Magee DE, Bekele A, Williams DC, Cullinan GJ, Bendele R, Kauffman RF, Bensch WR, Frolik CA, Termine JD, Bryant HU (1994) Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 93: 63–69
5. Clark JH, Paszko Z, Peck EJ Jr (1977) Nuclear binding and retention of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol. Endocrinology 100: 91–96
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3